FM
Therapeutic Areas
OKYO Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Urcosimod (OK-101) | Neuropathic Corneal Pain (NCP) | Phase 2 |
Leadership Team at OKYO Pharma
RD
Robert Dempsey
Chief Executive Officer/Director
GC
Gabriele Cerrone
Non-Executive Chairman
PH
Pedram Hamrah
Member of the Scientific Advisory Board
JS
Jay S. Pepose
Member of the Scientific Advisory Board
VP
Victor Perez
Member of the Scientific Advisory Board
AG
Anat Galor
Member of the Scientific Advisory Board
MM
Mina Massaro Giordano
Member of the Scientific Advisory Board